Scientists Are Encouraged By Data From Flesh-Eating Disease Studies
Progress is being made by scientists looking into the possible triggers of flesh-eating diseases like Fournier's Gangrene
Monday, February 25, 2019 - While the FDA warns that certain diabetic medications may be the cause of the rare genital flesh-eating disease Fournier's gangrene, scientist and researchers continue to work toward finding the triggers for Fournier's gangrene's underlying condition. Breakthroughs in analyzing the streptococcus virus give researchers hope that the condition can be effectively prevented in the years to come. Progress is being made to identify the possible triggers of necrotizing fasciitis, the condition that leads to Fournier's gangrene. The Center for Disease Control estimates that around 700 million cases of Group A streptococcus are reported every year in hospitals in the US, mostly as one form of "strep throat" or another. Up until recently, little was known what triggered this simple form of infection to progress into the deadly flesh-eating disease. According to the website Medical Express, "Houston Methodist infectious disease scientists have discovered a previously unknown trigger that turns a relatively run-of-the-mill infection into a devastatingly ravenous, flesh-eating disease." Fournier gangrene attorneys represent families and individuals diagnosed with necrotizing fasciitis due to diabetes drug infection.
The studies into the triggers of the flesh-eating disease are being led by James M. Musser, M.D., Ph.D., chairman of the Department of Pathology and Genomic Medicine at Houston Methodist. Dr. Musser and his team have studied the interactions between the three known forms of Strep A and have produced more data than has ever been accumulated with the hope of analyzing it using artificial intelligence. The goal of the research is to produce a vaccine to streptococcus A that has alluded scientists for over 100 years.
If a victim of Fournier's gangrene is one of the 20-40% of patients lucky enough to survive, partial or complete genital mutilation or complete amputation is certain. Up until recently, Fournier's gangrene was rare enough that people could cope with the thought of being the unlucky one to get the disease. Today, however, the US Food and Drug Administration warns that anyone taking certain drugs is at risk of contracting the disease, upping the risks considerably, particularly for the millions of people suffering from diabetes. Diabetes drugs classified as SGLT2 blockers taken by diabetics are the ones that present the greatest risk. 12 patients recently reported Fournier's gangrene to the FDA and all had been treated for diabetes with an SGLT2 drug. These types of drugs re-route sugars in the blood to the kidneys to be passed as urine. The FDA has identified the drugs linked with the 12 reported cases of Fournier's Gangrene as being Canagliflozin (Invokana, Invokamet, Invokamet XR), Dapagliflozin (Farxiga, Xigduo XR, Qtern), Empagliflozin (Jardiance, Glyxambi, Synjardy, Synjardy XR), and Ertugliflozin (Steglatro, Segluromet, Steglujan).
These drugs manufactured by leading pharmaceutical companies are now the subject of lawsuits that allege drug companies has a duty to warn patients that Fournier's gangrene was a possible outcome. If you are diabetic taking any of the above-mentioned medications and have contracted a flesh-eating disease, you should consult a Fournier's gangrene attorneys to see if you may be eligible for monetary compensation.
More Recent Diabetes Drug Infection Lawsuit News:
- Heart Disease Patients May Soon Be Prescribed Farxiga | 7/23/2020
- Diabetic Drug Farxiga Emerges As A Potential Cause of Fournier's Gangrene | 7/20/2020
- Diabetic Drug Companies Fail To Adequately Warn Patients of The Dangers of Developing Fournier's Gangrene | 7/15/2020
- A High Profile Fournier's Gangrene Victim May Serve To Increase Public Awareness | 6/25/2020
- The Flesh-Eating Disease Could Grow Exponentially in Summer of 2020 | 6/16/2020
- AstraZeneca Pharmaceutical Web Site Warns Patient About Possible Bacterial Infections | 6/5/2020
- New Fournier's Gangrene Victim Files Lawsuit Against AstraZeneca Pharmaceuticals LP | 6/3/2020
- Fornier's Gangrene is Easily Overlooked And Could be Called Complications From the Coronavirus | 5/26/2020
- Diabetic Nursing Home Patients May Be Dying From Fournier's Gangrene | 5/15/2020
- Diabetic Patients Taking SGLT2 Diabetic Drugs Could Be At Risk of Dying from COVID19 | 4/27/2020
- Fournier's Gangrene Looks Like Frostbite Except For Its Location | 4/21/2020
- Fournier's Gangrene More Likely Than Nursing Home Neglect In Patient's Death | 4/9/2020
- Nursing Homes Need To Pay Attention To Diabetic Patients Developing Fournier's Gangrene | 3/31/2020
- New Warning For SGLT2 Diabetes Drugs Include Fournier's Gangrene | 3/19/2020
- Popular Diabetic Drug Companies Are Warned To Alert Diabetic Patients of the Risks of Developing Fournier's Gangrene | 3/12/2020
- Patient's Fournier's Gangrene Can Be Mistaken For Ordinary Nursing Home Neglect | 3/5/2020
- Nursing Home Patients Taking Diabetic Medication Must Be Monitored For Fournier's Gangrene | 2/25/2020
- Simple Necrotizing Fasciitis Can Lead To Gruesome Fournier's Gangrene | 2/7/2020
- Fournier's Gangrene Can Cause Elephantitis of the Scrotum | 2/3/2020
- Diabetic Drugs Linked to Fournier's Gangrene May Treat Heart Conditions | 1/29/2020
- The Annals of Medicine Examines the Relationship Between Certain Diabetic Drugs and Fournier's Gangrene | 1/8/2020
- Diabetic Medications Can Cause Fournier's Gangrene And Other Health-Threatening Conditions | 12/31/2019
- Fournier's Gangrene Can Leave a Survivor Severely Depressed | 12/20/2019
- Woman's Cosmetic Surgery Leads to Flesh-Eating Disease of the Genitals | 12/16/2019
- Women Diagnosed With Orbital Necrotizing Fasciitis | 12/2/2019
- The Flesh-Eating Disease Has Made The News In 2019 | 11/22/2019
- Diabetic Drugs Can Weaken The Immune System Leading To Fournier's Gangrene | 11/11/2019
- SGLT-2 Drug Makers Are Being More Forthcoming About Links To Fournier's Gangrene | 10/31/2019
- Drug Marketers Are Finding Creative Applications For SGLT-2 Drugs Ignoring The Risk of Fournier's Gangrene | 10/24/2019
- Patient Contracts Flesh-Eating Disease While Giving Birth in a New York Hospital | 10/15/2019
- Weakened Immune Systems May Be The Cause of The Outbreak in Flesh-Eating Disease | 10/3/2019
- Fournier's Gangrene Stories Are One More Shocking Than Then The Last | 10/2/2019
- Sodium-Glucose Blocker Drugs and The Flesh-Eating Disease | 9/18/2019
- Diabetic Patients Are At Risk For Developing Fournier's Gangrene Mistaken as The Ordinary Flesh-Eating Disease | 9/2/2019
- SGLT2 Inhibitor Drugs Can Now Include Reducing Heart Disease on Their Labels In Europe | 8/29/2019
- Fournier's Gangrene Can Develop In Elderly Nursing Home Patients | 8/23/2019
- Elderly Diabetic Patients Are At Risk For Fournier's Gangrene | 8/7/2019
- Florida Nursing Home Death May Have Been From Fournier's Gangrene | 8/1/2019
- There is an Outbreak of The Flesh-Eating Disease Along America's Eastern Beaches | 7/23/2019
- Fournier's Gangrene Should Not Be Confused With Everyday Necrotising Fasciitis | 7/11/2019
- Johnson & Johnson Needs To Do More To Alert Diabetics of The Flesh Eating Disease Caused By Invokana | 6/28/2019
- Diabetic Patients Living in Warmers Climates Are More at Risk to Contract Fournier's Gangrene | 6/13/2019
- The Warm Water Gulf of Mexico May Be a Breeding Ground For The Flesh Eating Disease Bacteria | 6/7/2019
- Diabetic Patients in Nursing Homes Are Ground Zero For Fournier's Gangrene | 5/30/2019
- Several New Cases Of Flesh Eating Disease Have Been Recently Reported | 5/23/2019
- Cases Of Fournier's Gangrene Increases From 12 to 55 In The Latest Peer Reviewed Medical Study | 5/13/2019
- People Are Developing The Flesh-Eating Disease In Various Ways | 4/30/2019
- Most Doctors Remain Unaware of Fournier's Gangrene and May Misdiagnose Patients | 4/19/2019
- World Governments Are Expressing Concern That Certain Diabetes Drugs Can Cause Fournier's Gangrene | 4/15/2019
- Diabetic Drugs Can Have Serious Side Effects | 4/2/2019
- Necrotising Fasciitis Effects Everyone From All Walks of Life | 3/29/2019
- Cases of Fourniers Gangrene Are Steadily Increasing Around The World | 3/25/2019
- Global Warming and Climate Change May Be Contributing to Increases In Flesh Eating Diseases | 3/11/2019
- Early Warning Signs That You May Have Fournier's Gangrene or Other Flesh-Eating Disease | 3/6/2019
- The Brief History of Fournier's Gangrene | 2/20/2019
- FDA and CDC Warn About Flesh-Eating Diseases | 2/18/2019
- Diabetic Drug Warnings Admit to Causing Narcotizing Fasciitis Not Fournier's Gangrene Specifically | 2/11/2019
- Fournier's Gangrene Statistics May Be Greater Than Reported | 2/5/2019
- Diabetic Patients and Others Are At Risk For Fournier's Gangrene | 1/29/2019
- Fournier's Gangrene Frequently Asked Questions | 1/23/2019
- Diabetes Drugs Must Include Fournier's Gangrene Warning | 1/18/2019
- A Nursing Home's Elderly Diabetic Population Most at Risk For Fournier's Gangrene | 1/10/2019
- Diabetic Patients Should Be Vigilant In Watching For The Symptoms Of Fournier's Gangrene, A Flesh-Eating Disease That Can Affect The Genital Region | 1/4/2019
- An Indian Man Has Died of Fournier's Gangrene in a UK Hospital | 12/31/2018
- Pictures of Fournier's Gangrene Are Grotesque and Indescribable | 12/22/2018
- A Florida Nursing Home Patient Death Could be the 13th Case of Fournier's Gangrene | 12/20/2018
- Florida Man Dies From Genital Gangrene Quite Possibly Fournier's Gangrene | 12/15/2018
- The FDA's Fournier's Gangrene Warning is Shocking Diabetes Patients | 12/12/2018
- Drug Websites Carry The Clearest Fournier's Gangrene Amputation Warnings | 12/1/2018
- Recent FDA Warning Alerts Diabetes Patients To Watch For Signs of Genital Flesh-Eating Disease | 11/21/2018
- Diabetes Drugs May Cause Flesh-Eating Disease Affecting The Genitals | 11/1/2018
Lawyers for Fournier's Gangrene
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.